These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19007038)

  • 1. The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.
    Mikov M; Al-Salami H; Golocorbin-Kon S; Skrbic R; Raskovic A; Fawcett JP
    Eur J Drug Metab Pharmacokinet; 2008; 33(3):137-42. PubMed ID: 19007038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
    Al-Salami H; Butt G; Tucker I; Golocorbin-Kon S; Mikov M
    Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):99-108. PubMed ID: 21874525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats.
    Mikov M; Boni NS; Al-Salami H; Kuhajda K; Kevresan S; Golocorbin-Kon S; Fawcett JP
    Eur J Drug Metab Pharmacokinet; 2007; 32(1):7-12. PubMed ID: 17479538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.
    Al-Salami H; Butt G; Tucker I; Mikov M
    Methods Find Exp Clin Pharmacol; 2008 Mar; 30(2):107-13. PubMed ID: 18560625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats.
    Al-Salami H; Butt G; Tucker I; Mikov M
    Pharmacol Rep; 2008; 60(4):532-41. PubMed ID: 18799822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
    Al-Salami H; Butt G; Fawcett JP; Tucker IG; Golocorbin-Kon S; Mikov M
    Eur J Drug Metab Pharmacokinet; 2008; 33(2):101-6. PubMed ID: 18777945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.
    Al-Salami H; Butt G; Tucker I; Fawcett PJ; Golocorbin-Kon S; Mikov I; Mikov M
    Eur J Drug Metab Pharmacokinet; 2009; 34(1):43-50. PubMed ID: 19462928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat.
    Golocorbin-Kon S; Mikov M; Arafat M; Lepojevic Z; Mikov I; Sahman-Zaimovic M; Tomic Z
    Eur J Drug Metab Pharmacokinet; 2009; 34(1):31-6. PubMed ID: 19462926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats.
    Rasković A; Mikov M; Skrbić R; Jakovljević V; Vasović V; Posa M; Kuhajda K; Kevresan S; Tomic Z; Siladji D
    Eur J Drug Metab Pharmacokinet; 2008; 33(1):17-22. PubMed ID: 18543580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of novel microvesicles of basil, on blood glucose and the lipid profile: a preclinical study.
    Teofilovic B; Golocorbin-Kon S; Stilinovic N; Grujic-Letic N; Raškovic A; Mooranian A; Al-Salami H; Mikov M
    Sci Rep; 2021 Nov; 11(1):22123. PubMed ID: 34764416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliclazide: pharmacokinetic-pharmacodynamic relationships in rats.
    Stetinová V; Kvetina J; Pastera J; Polásková A; Prazáková M
    Biopharm Drug Dispos; 2007 Jul; 28(5):241-8. PubMed ID: 17415747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
    Arafat M; Kirchhoefer C; Mikov M
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.
    Golocorbin-Kon S; Calasan J; Milijasevic B; Vukmirovic S; Lalic-Popovic M; Mikov M; Al-Salami H
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):1005-1011. PubMed ID: 28547295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations and hypoglycemic effect of gliclazide: crosspovidone solid dispersion on streptozotocin induced diabetic rats.
    Adibkia K; Babaei H; Asnaashari S; Andalib S; Khorrami A; Ghavimi H; Jadidinia V; Hajiloo H; Barzegar-Jalali M
    Drug Res (Stuttg); 2013 Feb; 63(2):94-7. PubMed ID: 23427050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits.
    Satyanarayana S; Kilari EK
    Mol Cell Biochem; 2006 Oct; 291(1-2):101-5. PubMed ID: 16715184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
    Abdelkader NF; Eitah HE; Maklad YA; Gamaleldin AA; Badawi MA; Kenawy SA
    Life Sci; 2020 Apr; 247():117458. PubMed ID: 32092333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
    Yazgan ÜC; Taşdemir E; Bilgin HM; Deniz Obay B; Şermet A; Elbey B
    Arch Physiol Biochem; 2015; 121(4):157-61. PubMed ID: 26161595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats.
    Satyanarayana S; Sekhar JR; Kumar KE; Shannika LB; Rajanna B; Rajanna S
    Mol Cell Biochem; 2006 Feb; 283(1-2):123-7. PubMed ID: 16444594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.